Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.57 USD | -19.58% | -23.59% | -41.99% |
07:58pm | Top Midday Decliners | MT |
03:45pm | BofA Securities Downgrades Sage Therapeutics to Underperform From Neutral, Adjusts Price Target to $14 From $24 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.99% | 939M | |
-3.39% | 102B | |
+2.61% | 96.09B | |
-1.02% | 22.05B | |
-18.14% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.89% | 14.01B | |
+1.12% | 13.38B | |
+22.25% | 11.01B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Sage Therapeutics : Biogen Say Zuranolone Study Meets Primary Endpoint in Patients With Major Depressive Disorder